about
Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11)Gag-Specific CD8 T-Cell Proliferation Is Associated With Higher Peripheral Blood Levels of Transforming Growth Factor-β and Gut-Homing T Cells in Youths Perinatally Infected With Human Immunodeficiency Virus-1: The ANRS-EP38-IMMIP Study.Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?Interruption of cART in clinical practice is associated with an increase in the long-term risk of subsequent immunosuppression in HIV-1-infected children.Increased risk of serious bacterial infections due to maternal immunosuppression in HIV-exposed uninfected infants in a European country.In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.Population pharmacokinetics of atazanavir/ritonavir in HIV-1-infected children and adolescents.No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.Gag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity - The ANRS-EP38-IMMIP Study.Evaluation of nevirapine dosing recommendations in HIV-infected children.Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcomeEfficacy and tolerance of dolutegravir-based combined ART in perinatally HIV-1-infected adolescents: a French multicentre retrospective study.Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women?Gag-Specific CD4 T Cell Proliferation, Plasmacytoid Dendritic Cells, and Ethnicity in Perinatally HIV-1-Infected Youths: The ANRS-EP38-IMMIP Study.HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report.Risk of cancer in children exposed to didanosine in utero.Naive T lymphocytes and recent thymic emigrants are associated with HIV-1 disease history in french adolescents and young adults infected in the perinatal period: the ANRS-EP38-IMMIP study.
P50
Q28538279-EEB58CDC-11B4-46AF-B434-270C8A6BE034Q33629212-C40127E7-F030-40FA-87BD-4EE095D32AD9Q34752077-1D510D19-3788-4CA8-9771-3781B6BE8DB7Q35191380-EF3A0375-8021-4513-8B87-7F68B354D468Q35211424-810A15D7-CC49-4740-8005-D45816A94345Q35594678-83E5630F-31F8-49A7-926F-8728370ACD39Q35629777-0156979C-FACA-44C2-A21C-06A4A00BA937Q35703796-86BF1F2A-D144-4259-BEF0-8F6629A9D671Q35864285-5180621E-6642-49A1-B2ED-EF33D3CBE1F5Q36988025-6922C240-45DD-4BB9-9F26-858804185D54Q37373179-08C101D6-C165-4169-B17B-11310655A5B4Q39080586-C7BFBC30-F191-432E-AC03-1FC9365D6761Q39102276-D482B6E5-4592-4D6B-8F9A-599EE658BBCAQ39390813-ADBEAB29-6DF9-44D4-BDEB-67F0FB1BF84AQ40834710-15C8ADBB-E705-4934-8548-7EDFAC1C0DE4Q40923525-9C2A6758-61F6-4134-8833-7264C13FDFDFQ42240026-E51B017B-0B0A-4AF4-9A46-755A8A7AB7CB
P50
description
onderzoeker
@nl
name
Catherine Dollfus
@ast
Catherine Dollfus
@en
Catherine Dollfus
@es
Catherine Dollfus
@nl
Catherine Dollfus
@sl
type
label
Catherine Dollfus
@ast
Catherine Dollfus
@en
Catherine Dollfus
@es
Catherine Dollfus
@nl
Catherine Dollfus
@sl
prefLabel
Catherine Dollfus
@ast
Catherine Dollfus
@en
Catherine Dollfus
@es
Catherine Dollfus
@nl
Catherine Dollfus
@sl